Take your foot out your mouth and do some research.
OM will be manufactured and marketed by Amgen.
T will be manufactured and marketed by Cytokinetics.
Wait one second @#$% . I never asked this question before ! People on this board have been redundant about stupid questions and you come down on me for a legitimate question.
Is something wrong here ?
Enrollment is only 128 with 58 study locations ?
And still recruiting.
Is the clinicaltrials.gov wrong about the completion date October 2014 ?
The real question should be why did Osiris abandon it's MPCs business.
Then we should be discussing whether MAPCs have an advantage over MPCs.
MAPCs in the news.
New Stem Cell Therapy Could Improve Cognitive Function After ...
BioNews Texas-by Anna Ishibashi-Nov 5, 2013Share
Cox's team injected MAPC in two groups of brain-injured mice at 2 hours and 24 hours after the mice were injured. The dose was 2 million ..
Why is there a lack of interest from Institution and Fund managers to buy into PSTI ?
Who owns the majority of shares ?
Nov. 7, 2013, 9:54 a.m. EST
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine
How would you want management to communicate better ? Why the mistrust ?
We certainly don't want some Law Office of So and So involved at this point in time because something was said that could be misconstrued.
Why did you leave out CYTK as one of your fleecing biotechs on this board.
I'm sure you have not lost your short term memory. Slimy dog !
Anyone that listened to you in the short term may have saved some money, but those that continue to accumulate at these depressed prices will be rewarded someday.